tradingkey.logo
tradingkey.logo
Pesquisar

Inotiv Inc

NOTV
Adicionar à lista de desejos
0.080USD
0.0000.00%
Fechamento 06/30, 16:00ETCotações atrasadas em 15 min
2.79MValor de mercado
PerdaP/L TTM

Mais detalhes de Inotiv Inc Empresa

Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Informações de Inotiv Inc

Código da empresaNOTV
Nome da EmpresaInotiv Inc
Data de listagemNov 25, 1997
CEOLeasure (Robert W)
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 25
Endereço2701 Kent Ave
CidadeWEST LAFAYETTE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal47906-1382
Telefone13174634527
Sitehttps://www.inotiv.com/
Código da empresaNOTV
Data de listagemNov 25, 1997
CEOLeasure (Robert W)

Executivos da empresa Inotiv Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
686.00K
-0.88%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
373.36K
-1.44%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
180.99K
-3.19%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
104.93K
+26.21%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
76.89K
+35.76%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
13.20K
-43.94%
Mr. R. Matthew Neff
Mr. R. Matthew Neff
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert W. Leasure, Jr.
Mr. Robert W. Leasure, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Beth A. Taylor
Ms. Beth A. Taylor
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Mr. David Landman
Mr. David Landman
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
686.00K
-0.88%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
373.36K
-1.44%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
180.99K
-3.19%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
104.93K
+26.21%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
76.89K
+35.76%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
13.20K
-43.94%

Perguntas frequentes

Quem são os cinco principais acionistas de Inotiv Inc?

Os cinco principais acionistas de Inotiv Inc são: Dr. John E. Sagartz, Ph.D.

Quantas instituições possuem ações da Inotiv Inc (NOTV)?

Em 2026Q1, 168 instituições possuíam ações da Inotiv Inc, com valor de mercado aproximado de 8.11M, representando 23.58% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -4802422.00.
KeyAI